Intevac Announces Third Quarter 2015 Financial Results
Mon, November 2 2015
“I’m pleased to report that in the third quarter we achieved the highest
level of bookings in over two years, including over $19 million in
Thin-film Equipment orders and over $8 million in Photonics orders,”
commented
“In our Photonics business, we were awarded a $25 million funding
vehicle from the
($ Millions, except per share amounts) | Q3 2015 | Q3 2014 | ||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 18.4 | $ | 18.4 | $ | 14.8 | $ | 14.8 | ||||||||
Operating Loss | $ | (3.8 | ) | $ | (3.9 | ) | $ | (4.1 | ) | $ | (4.2 | ) | ||||
Net Loss | $ | (3.8 | ) | $ | (3.9 | ) | $ | (3.6 | ) | $ | (3.6 | ) | ||||
Net Loss per Share | $ | (0.17 | ) | $ | (0.18 | ) | $ | (0.15 | ) | $ | (0.15 | ) | ||||
|
Nine Months Ended | Nine Months Ended | ||||||||||||||
|
|
|||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 58.8 | $ | 58.8 | $ | 46.5 | $ | 46.5 | ||||||||
Operating Loss | $ | (6.4 | ) | $ | (6.6 | ) | $ | (14.1 | ) | $ | (13.7 | ) | ||||
Net Loss | $ | (6.6 | ) | $ | (6.8 | ) | $ | (13.1 | ) | $ | (12.8 | ) | ||||
Net Loss per Share | $ | (0.29 | ) | $ | (0.30 | ) | $ | (0.55 | ) | $ | (0.54 | ) | ||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Third Quarter 2015 Summary
The net loss for the quarter was
Revenues were
Thin-film Equipment gross margin was 17.8% compared to (9.5)% in the third quarter of 2014 and 41.0% in the second quarter of 2015. The decline from the second quarter of 2015 reflected the lower margin on the first MATRIX PVD system for solar panels recognized for revenue. The improvement from the third quarter of 2014 reflected a higher level of revenue and improved factory absorption.
Photonics gross margin was 35.5% compared to 45.1% in the third quarter of 2014 and 34.5% in the second quarter of 2015. The decline from the third quarter of 2014 was due to lower contractual pricing on shipments of the Apache helicopter camera and higher factory overhead due to the modified cost structure implemented in the second quarter of 2015. Consolidated gross margin was 26.7%, compared to 32.6% in the third quarter of 2014 and 38.2% in the second quarter of 2015.
R&
Order backlog totaled
The company ended the quarter with
First Nine Months 2015 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 30.0%, compared to 12.3% in the first nine months of 2014, the increase primarily due to higher mix of higher-margin upgrades, lower factory overhead expenses and lower inventory charges. Photonics gross margin was 37.4% compared to 42.4% in the first nine months of 2014, reflecting lower contractual pricing on Apache camera shipments and higher factory overhead due to the modified cost structure implemented in the second quarter of 2015. Consolidated gross margin was 33.4%, compared to 31.9% in the first nine months of 2014.
R&
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PST (4:30 p.m. EST). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-Film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties.
In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital night vision imaging systems for the U.S. military.
For more information call 408-986-9888, or visit the company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(Unaudited, in thousands, except per share amounts) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
|
|
|
|
|||||||||||||
Net revenues | ||||||||||||||||
Thin-film Equipment | $ | 9,192 | $ | 3,375 | $ | 31,314 | $ | 16,184 | ||||||||
Photonics | 9,226 | 11,382 | 27,448 | 30,304 | ||||||||||||
Total net revenues | 18,418 | 14,757 | 58,762 | 46,488 | ||||||||||||
Gross profit | 4,912 | 4,815 | 19,640 | 14,836 | ||||||||||||
Gross margin | ||||||||||||||||
Thin-film Equipment | 17.8 | % | (9.5 | )% | 30.0 | % | 12.3 | % | ||||||||
Photonics | 35.5 | % | 45.1 | % | 37.4 | % | 42.4 | % | ||||||||
Consolidated | 26.7 | % | 32.6 | % | 33.4 | % | 31.9 | % | ||||||||
Operating expenses | ||||||||||||||||
Research and development | 3,956 | 3,986 | 11,511 | 12,817 | ||||||||||||
Selling, general and administrative | 4,886 | 4,991 | 14,915 | 16,055 | ||||||||||||
Acquisition-related1 | (150 | ) | (78 | ) | (350 | ) | 19 | |||||||||
Total operating expenses | 8,692 | 8,899 | 26,076 | 28,891 | ||||||||||||
Total operating loss | (3,780 | ) | (4,084 | ) | (6,436 | ) | (14,055 | ) | ||||||||
Operating income (loss) | ||||||||||||||||
Thin-film Equipment | (3,935 | ) | (5,872 | ) | (7,226 | ) | (15,681 | ) | ||||||||
Photonics | 1,308 | 3,120 | 4,060 | 6,595 | ||||||||||||
Corporate | (1,153 | ) | (1,332 | ) | (3,270 | ) | (4,969 | ) | ||||||||
Total operating income (loss) | (3,780 | ) | (4,084 | ) | (6,436 | ) | (14,055 | ) | ||||||||
Interest income and other income (expense), net | 23 | 113 | 88 | 306 | ||||||||||||
Loss before income taxes | (3,757 | ) | (3,971 | ) | (6,348 | ) | (13,749 | ) | ||||||||
Provision for (benefit from) income taxes | 2 | (412 | ) | 292 | (662 | ) | ||||||||||
Net loss | $ | (3,759 | ) | $ | (3,559 | ) | $ | (6,640 | ) | $ | (13,087 | ) | ||||
Net Loss per share | ||||||||||||||||
Basic and Diluted | $ | (0.17 | ) | $ | (0.15 | ) | $ | (0.29 | ) | $ | (0.55 | ) | ||||
Weighted average common shares outstanding | ||||||||||||||||
Basic and Diluted |
22,004 | 23,657 | 22,621 | 23,814 | ||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||||||
|
|||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(In thousands, except par value) |
|||||||
|
|
||||||
(Unaudited) | (see Note) | ||||||
ASSETS |
|||||||
Current assets | |||||||
Cash, cash equivalents and short-term investments |
$ |
47,055 |
$ |
51,080 |
|||
Accounts receivable, net | 13,558 | 12,087 | |||||
Inventories | 15,659 | 19,212 | |||||
Prepaid expenses and other current assets | 1,728 | 1,727 | |||||
Total current assets | 78,000 | 84,106 | |||||
Long-term investments | 7,303 | 17,542 | |||||
Restricted cash | 1,780 | 1,780 | |||||
Property, plant and equipment, net | 11,934 | 12,826 | |||||
Intangible assets, net | 3,326 | 3,966 | |||||
Other long-term assets | 1,540 | 55 | |||||
Total assets | $ | 103,883 | $ | 120,275 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||||||
Current liabilities | |||||||
Accounts payable | $ | 4,233 | $ | 4,640 | |||
Accrued payroll and related liabilities | 3,610 | 3,977 | |||||
Other accrued liabilities | 3,806 | 8,277 | |||||
Customer advances | 4,413 | 2,551 | |||||
Total current liabilities | 16,062 | 19,445 | |||||
Other long-term liabilities | 2,509 | 2,200 | |||||
Stockholders’ equity | |||||||
Common stock ( |
22 | 23 | |||||
Additional paid-in capital | 165,668 | 161,271 | |||||
|
(20,937) | (9,989 | ) | ||||
Accumulated other comprehensive income | 493 | 619 | |||||
Accumulated deficit | (59,934) | (53,294 | ) | ||||
Total stockholders’ equity | 85,312 | 98,630 | |||||
Total liabilities and stockholders’ equity | $ | 103,883 | $ | 120,275 | |||
Note: Amounts as of |
|||||||
|
||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | ||||||||||||||||
(Unaudited, in thousands, except per share amounts) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
|
|
|
|
|||||||||||||
Non-GAAP Loss from Operations | ||||||||||||||||
Reported operating loss (GAAP basis) | $ | (3,780 | ) | $ | (4,084 | ) | $ | (6,436 | ) | $ | (14,055 | ) | ||||
Change in fair value of contingent consideration obligations1 | (150 | ) | (78 | ) | (350 | ) | 19 | |||||||||
Restructuring charges2 | — | — | 148 | 288 | ||||||||||||
Non-GAAP Operating Loss | $ | (3,930 | ) | $ | (4,162 | ) | $ | (6,638 | ) | $ | (13,748 | ) | ||||
Non-GAAP Net Loss | ||||||||||||||||
Reported net loss (GAAP basis) | $ | (3,759 | ) | $ | (3,559 | ) | $ | (6,640 | ) | $ | (13,087 | ) | ||||
Change in fair value of contingent consideration obligations1 | (150 | ) | (78 | ) | (350 | ) | 19 | |||||||||
Restructuring charges2 | — | — | 148 | 288 | ||||||||||||
Non-GAAP Net Loss | $ | (3,909 | ) | $ | (3,637 | ) | $ | (6,842 | ) | $ | (12,780 | ) | ||||
Non-GAAP Net Loss Per Diluted Share | ||||||||||||||||
Reported net loss per diluted share (GAAP basis) | $ | (0.17 | ) | $ | (0.15 | ) | $ | (0.29 | ) | $ | (0.55 | ) | ||||
Change in fair value of contingent consideration obligations1 | (0.01 | ) | — | (0.02 | ) | — | ||||||||||
Restructuring charges2 | — | — | 0.01 | 0.01 | ||||||||||||
Non-GAAP Net Loss Per Diluted Share | $ | (0.18 | ) | $ | (0.15 | ) | $ | (0.30 | ) | $ | (0.54 | ) | ||||
Weighted average number of diluted shares | 22,004 | 23,657 | 22,621 | 23,814 | ||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||||||
2Results for all periods presented include severance and other employee-related costs related to various restructuring programs. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005652/en/
Chief Financial Officer
or
Investor Relations
Source: